Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.2 CHF | 0.00% | -3.75% | -3.86% |
Feb. 16 | BB Biotech's Loss Narrows in FY23; Operating Income Down | MT |
Feb. 14 | BB Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 190M 208M | Sales 2025 * | 101M 110M | Capitalization | 2.26B 2.48B |
---|---|---|---|---|---|
Net income 2024 * | 152M 167M | Net income 2025 * | 72M 78.95M | EV / Sales 2024 * | 13.4 x |
Net Debt 2024 * | 291M 319M | Net Debt 2025 * | 324M 356M | EV / Sales 2025 * | 25.7 x |
P/E ratio 2024 * |
14.9
x | P/E ratio 2025 * |
13.8
x | Employees | 10 |
Yield 2024 * |
5.7% | Yield 2025 * |
5.83% | Free-Float | 97.24% |
1 week | -3.28% | ||
Current month | -9.33% | ||
1 month | -8.63% | ||
3 months | -6.14% | ||
6 months | +12.23% | ||
Current year | -3.39% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 41.1 | -0.24% | 52 867 |
24-04-22 | 41.2 | -0.48% | 63,519 |
24-04-19 | 41.4 | -0.84% | 62,131 |
24-04-18 | 41.75 | -0.83% | 61,488 |
24-04-17 | 42.1 | -1.41% | 82,022 |
Delayed Quote Swiss Exchange, April 23, 2024 at 04:54 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.39% | 2.48B | |
-0.02% | 42.11B | |
+46.11% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- BION Stock